23/120
1.0 / 5 stars
All 120 Win/Lose results shown below
MRKR Roast Me summary
Marker Therapeutics, Inc. (MRKR). Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
Trailing 1 year (4 quarters): 1 wins, 11 lossesLast fetched: 24 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseMRKR / S&P 13.08% / 15.20% |
LoseMRKR / S&P MRKR unavailable / 15.00% |
LoseMRKR / S&P MRKR unavailable / 50.40% |
| 2026-Q10/3 |
LoseMRKR / S&P -12.75% / -4.33% |
LoseMRKR / S&P -30.67% / 11.30% |
LoseMRKR / S&P MRKR unavailable / 27.70% |
| 2025-Q41/3 |
WinMRKR / S&P 67.42% / 2.65% |
LoseMRKR / S&P -46.19% / 9.00% |
LoseMRKR / S&P MRKR unavailable / 13.40% |
| 2025-Q30/3 |
LoseMRKR / S&P -41.83% / 8.12% |
LoseMRKR / S&P -12.99% / 4.61% |
LoseMRKR / S&P MRKR unavailable / 13.45% |
| 2025-Q22/3 |
WinMRKR / S&P 24.39% / 10.94% |
WinMRKR / S&P 44.55% / 4.83% |
LoseMRKR / S&P MRKR unavailable / 10.63% |
| 2025-Q11/3 |
LoseMRKR / S&P -60.45% / -4.27% |
WinMRKR / S&P 71.53% / 4.98% |
LoseMRKR / S&P MRKR unavailable / 10.57% |
| 2024-Q42/3 |
WinMRKR / S&P 10.28% / 2.41% |
WinMRKR / S&P 99.06% / 5.25% |
LoseMRKR / S&P MRKR unavailable / 6.15% |
| 2024-Q31/3 |
LoseMRKR / S&P -48.07% / 5.89% |
WinMRKR / S&P 79.04% / 5.89% |
LoseMRKR / S&P MRKR unavailable / 6.11% |
| 2024-Q21/3 |
WinMRKR / S&P 26.28% / 4.28% |
LoseMRKR / S&P -0.75% / 5.38% |
LoseMRKR / S&P MRKR unavailable / 5.12% |
| 2024-Q10/3 |
LoseMRKR / S&P -21.82% / 10.56% |
LoseMRKR / S&P -12.23% / 5.71% |
LoseMRKR / S&P MRKR unavailable / 5.59% |
| 2023-Q41/3 |
WinMRKR / S&P 21.15% / 11.69% |
LoseMRKR / S&P -5.76% / 6.81% |
LoseMRKR / S&P MRKR unavailable / 7.78% |
| 2023-Q31/3 |
WinMRKR / S&P 46.45% / -3.27% |
LoseMRKR / S&P MRKR unavailable / 7.52% |
LoseMRKR / S&P MRKR unavailable / -5.03% |
| 2023-Q21/3 |
WinMRKR / S&P 336.62% / 8.74% |
LoseMRKR / S&P MRKR unavailable / 9.50% |
LoseMRKR / S&P MRKR unavailable / -8.57% |
| 2023-Q10/3 |
LoseMRKR / S&P -73.70% / 7.50% |
LoseMRKR / S&P MRKR unavailable / 10.77% |
LoseMRKR / S&P MRKR unavailable / -15.69% |
| 2022-Q41/3 |
LoseMRKR / S&P -27.03% / 7.56% |
WinMRKR / S&P 182.96% / 11.88% |
LoseMRKR / S&P MRKR unavailable / -17.99% |
| 2022-Q31/3 |
WinMRKR / S&P 12.12% / -4.88% |
LoseMRKR / S&P MRKR unavailable / 13.47% |
LoseMRKR / S&P MRKR unavailable / -1.41% |
| 2022-Q20/3 |
LoseMRKR / S&P -25.00% / -16.10% |
LoseMRKR / S&P MRKR unavailable / 13.71% |
LoseMRKR / S&P MRKR unavailable / 11.04% |
| 2022-Q10/3 |
LoseMRKR / S&P -53.68% / -4.60% |
LoseMRKR / S&P MRKR unavailable / 15.97% |
LoseMRKR / S&P MRKR unavailable / 42.23% |
| 2021-Q41/3 |
LoseMRKR / S&P -43.79% / 11.03% |
WinMRKR / S&P 166.01% / 15.00% |
LoseMRKR / S&P MRKR unavailable / 96.40% |
| 2021-Q30/3 |
LoseMRKR / S&P -39.43% / 0.58% |
LoseMRKR / S&P MRKR unavailable / 10.77% |
LoseMRKR / S&P MRKR unavailable / 69.42% |
| 2021-Q21/3 |
WinMRKR / S&P 24.55% / 8.55% |
LoseMRKR / S&P MRKR unavailable / 6.58% |
LoseMRKR / S&P MRKR unavailable / 51.81% |
| 2021-Q11/3 |
WinMRKR / S&P 54.48% / 6.17% |
LoseMRKR / S&P MRKR unavailable / -1.06% |
LoseMRKR / S&P MRKR unavailable / 7.39% |
| 2020-Q41/3 |
LoseMRKR / S&P -3.33% / 12.15% |
WinMRKR / S&P 118.95% / -3.72% |
LoseMRKR / S&P MRKR unavailable / -33.42% |
| 2020-Q30/3 |
LoseMRKR / S&P -27.54% / 8.93% |
LoseMRKR / S&P MRKR unavailable / -2.04% |
LoseMRKR / S&P MRKR unavailable / -27.10% |
| 2020-Q20/3 |
LoseMRKR / S&P 8.95% / 20.54% |
LoseMRKR / S&P MRKR unavailable / -0.46% |
LoseMRKR / S&P MRKR unavailable / -27.11% |
| 2020-Q10/3 |
LoseMRKR / S&P -34.03% / -19.60% |
LoseMRKR / S&P MRKR unavailable / 3.47% |
LoseMRKR / S&P MRKR unavailable / -14.75% |
| 2019-Q40/3 |
LoseMRKR / S&P -43.64% / 9.07% |
LoseMRKR / S&P MRKR unavailable / 5.36% |
LoseMRKR / S&P MRKR unavailable / 2.99% |
| 2019-Q30/3 |
LoseMRKR / S&P -35.48% / 1.70% |
LoseMRKR / S&P MRKR unavailable / 5.02% |
LoseMRKR / S&P MRKR unavailable / 0.21% |
| 2019-Q21/3 |
WinMRKR / S&P 20.00% / 4.30% |
LoseMRKR / S&P MRKR unavailable / 6.64% |
LoseMRKR / S&P MRKR unavailable / 8.65% |
| 2019-Q11/3 |
WinMRKR / S&P 18.92% / 13.65% |
LoseMRKR / S&P MRKR unavailable / 8.12% |
LoseMRKR / S&P MRKR unavailable / 14.29% |
| 2018-Q40/3 |
LoseMRKR / S&P -38.67% / -13.52% |
LoseMRKR / S&P MRKR unavailable / 9.05% |
LoseMRKR / S&P MRKR unavailable / 18.23% |
| 2018-Q30/3 |
LoseMRKR / S&P -4.03% / 7.71% |
LoseMRKR / S&P MRKR unavailable / 10.21% |
LoseMRKR / S&P MRKR unavailable / 19.06% |
| 2018-Q21/3 |
WinMRKR / S&P 178.99% / 3.43% |
LoseMRKR / S&P MRKR unavailable / 9.03% |
LoseMRKR / S&P MRKR unavailable / 14.46% |
| 2018-Q10/3 |
LoseMRKR / S&P -13.78% / -0.76% |
LoseMRKR / S&P MRKR unavailable / 7.68% |
LoseMRKR / S&P MRKR unavailable / 12.46% |
| 2017-Q41/3 |
WinMRKR / S&P 30.23% / 6.64% |
LoseMRKR / S&P MRKR unavailable / 7.03% |
LoseMRKR / S&P MRKR unavailable / 13.82% |
| 2017-Q30/3 |
LoseMRKR / S&P -22.42% / 4.48% |
LoseMRKR / S&P MRKR unavailable / 5.68% |
LoseMRKR / S&P MRKR unavailable / 17.57% |
| 2017-Q20/3 |
LoseMRKR / S&P -13.59% / 3.09% |
LoseMRKR / S&P MRKR unavailable / 4.83% |
LoseMRKR / S&P MRKR unavailable / 17.74% |
| 2017-Q11/3 |
WinMRKR / S&P 15.72% / 6.07% |
LoseMRKR / S&P MRKR unavailable / 3.67% |
LoseMRKR / S&P MRKR unavailable / 13.32% |
| 2016-Q40/3 |
LoseMRKR / S&P -42.00% / 3.82% |
LoseMRKR / S&P MRKR unavailable / 2.09% |
LoseMRKR / S&P MRKR unavailable / 7.05% |
| 2016-Q31/3 |
WinMRKR / S&P 9.31% / 3.85% |
LoseMRKR / S&P MRKR unavailable / 0.20% |
LoseMRKR / S&P MRKR unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | MRKR total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 56.99% | 20.78% |
| Annualized return | 56.99% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | MRKR total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -92.55% | 83.14% |
| Annualized return | -40.51% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | MRKR total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -97.47% | 319.30% |
| Annualized return | -30.75% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-24.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |